Introduction: The no-scalpel vasectomy is the most common standard vasectomy technique worldwide. We aimed to evaluate the effects of vasectomy and re-vasectomy on erectile function and life quality. Materials and Methods: Two hundred and twelve consecutive vasectomy patients were evaluated. Validated SF-36 and IIEF assessment questionnaires were completed for the patients at the day of vasectomy and during 3rd, 6th, and 12th month controls. Patients were evaluated for complications within the first 7 days. Re-vasectomy was performed when motile sperms were detected at the 6th month control spermiogram. Results: The mean IIEF scores showed a significant increase (p < 0.05), whereas the mean SF-36 subscales did not show any difference (p > 0.05). In the re-vasectomy group, no statistically significant difference was detected between the mean values of IIEF scores and SF-36 subscales (p > 0.05). Of the 18 patients having motile sperms at the 6th month control, 12 were performed re-vasectomy, while 6 did not accept re-operation and were excluded. 186 patients were prospectively evaluated in the vasectomy group. Only 1 (0.45%) patient had hematoma. Conclusion: Our results showed the positive effect of vasectomy on erectile function. Also, re-vasectomy had no additional positive or negative effects on erectile function and quality of life.
Giriş: No-scalpel vazektomi dünyada en yaygın kullanılan standart vazektomi tekniğidir. Bizim amacımız vazektomi ve re-vazektominin erektil fonksiyon ve yaşam kalitesi üzerindeki etkisinini araştırmaktır. Gereç ve Yöntem: İkiyüzoniki adet vazektomi hastası değerlendirildi. Hastalar vazektomi gününde, 3.ay, 6.ay ve 12. aylık kontrollerinde valide edilmiş SF-36 ve İİEF sorgulama formlarıyla değerlendirildi. Komplikasyon açısında ilk 7 günde hastalar değerlendirildi. Altıncı ay kontrol spermiyogramında motil sperm görülen hastalara revazektomi uygulandı. Bulgular: Ortalama İİEF skorunda istatiksel anlamlı artış tespit edilirken (p < 0.05) ortalama SF-36 subskalasında herhangi bir fark görülmedi ( p > 0.05).Re-vazektomi grubunda İİEF skorlarında ve SF-36 subskalasında istatiksel anlamlı fark görülmedi (p > 0.05).Altıncı ay kontrollerinde motil sperm görülen 18 hastanın 12’ne re-vazektomi uygulandı,6 hasta ameliyatı kabul etmedigi için çalışma dışı bırakıldı. Vazektomi grubunda 186 hasta prospektif olarak değerlendirildi. Sadece 1(0.45%) hastada hematom görüldü. Sonuç: Bizim sonuçlarımızda vazektominin erektil fonksiyon üzerinde pozitif etkisi görüldü. Bununla birlikte revazektominin erektil fonksiyon ve yaşam kalitesi üzerine herhangi pozitif veya negatif etkisi tespit edilmedi.
___
1. Miller WB, Shain RN, Pasta DJ . Tubal sterilization or vasectomy: how do married couples make the choice? Fertil Steril 1991; 56(2): 278-84.
2. Li SQ, Goldstein M, Zhu J, Huber D. The no-scalpel vasectomy. J Urol 1991; 145(2): 341-4.
3. Weiss RS, Li PS. No-needle jet anesthetic technique for no-scalpel vasectomy. J Urol 2005; 173(5):1677-80.
4. Trussell J, Lalla AM, Doan QV, Reyes E, Pinto L, Gricar J. Cost effectiveness of contraceptives in the United States. Contraception 2009; 79(1): 5-14.
5. Hemingway H, Stafford M, Stansfeld S, Shipley M, Marmot M. Is the SF-36 a valid measure of change in population health? Results from the Whitehall II Study. BMJ 1997; 315(7118):1273-9.
6. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49(6):822-30.
7. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30(6):473-83.
8. Li PS, Li SQ, Schlegel PN, Goldstein M . External spermatic sheath injection for vasal nerve block. Urology 1992;39(2):173- 6.
9. No-scalpel vasectomy an Illustrated Guide for Surgeon.3rd ed.New York: Engender Health;2003.
10. Holt BA, Higgins AF. Minimally invasive vasectomy. Br J Urol 1996;77(4):585-6.
11. Sokal DC, McMullen S, Gates D, Dominik R . A comparative study of the no scalpel and standard incision approaches to vasectomy in 5 countries. The Male Sterilization Investigator Team 1999; 162(5):1621-5.
12. Nirapathpongporn A, Huber DH, Krieger JN . No-scalpel vasectomy at the King's birthday vasectomy festival. Lancet 1990; 14(335): 894-5.
13. Manikandan R, Srirangam SJ, Pearson E, Collins GN. Early and late morbidity after vasectomy: a comparison of chronic scrotal pain at 1 and 10 years. BJU Int 2004;93(4):571-4.
14. Myers SA, Mershon CE, Fuchs EF. Vasectomy reversal for treatment of the post-vasectomy pain syndrome. J Urol 1997;157(2):518-20.
15. Schmidt SS . Vasectomy by section, luminal fulguration and fascial interposition: results from 6248 cases. Br J Urol 1995; 76(3):373-4; discussion 375.
16. McMahon AJ, Buckley J, Taylor A, Lloyd SN, Deane RF, Kirk D . Chronic testicular pain following vasectomy. Br J Urol 1992;69(2):188-91.
17. Sharlip ID, Belker AM, Honig S, Labrecque M, Marmar JL, Ross LS et al. American Urological Association . Vasectomy: AUA guideline. J Urol. 2012; 188(6 Suppl):2482-91.
18. Kendrick JS, Gonzales B, Huber DH, Grubb GS, Rubin GL. Complications of vasectomies in the United States. J Fam Pract 1987;25(3):245-8.
19. Barone MA, Nazerali H, Cortes M, Chen-Mok M, Pollack AE, Sokal D. A prospective study of time and number of ejaculations to azoospermia after vasectomy by ligation and excision. J Urol 2003;170(3):892-6.
20. Barone MA, Irsula B, Chen-Mok M, Sokal DC; Investigator study group . Effectiveness of vasectomy using cautery.BMC Urol 2004;19;4:10.
21. Belker AM, Sexter MS, Sweitzer SJ, Raff MJ . The high rate of noncompliance for post-vasectomy semen examination: medical and legal considerations. J Urol 1990; 144(2 Pt 1): 284-6.
22. Schwingl PJ, Guess HA. Safety and effectiveness of vasectomy. Fertil Steril 2000; 73(5): 923-36.
23. Hendry WF . Vasectomy and vasectomy reversal. Br J Urol 1994; 73(4): 337-44.
24. Goldacre MJ, Holford TR, Vessey MP . Cardiovascular disease and vasectomy. Findings from two epidemiologic studies. N Engl J Med 1983; 308(14): 805-8.
25. Rosenberg L, Schwingl PJ, Kaufman DW, Helmrich SP, Palmer JR, Shapiro S . The risk of myocardial infarction 10 or more years after vasectomy in men under 55 years of age. Am J Epidemiol 1986; 123(6): 1049-56.
26. Coady SA, Sharrett AR, Zheng ZJ, Evans GW, Heiss G.Vasectomy,inflammation, atherosclerosis and long-term followup for cardiovascular diseases: no associations in the atherosclerosis risk in communities study. J Urol 2002; 167(1): 204-7.
27. Manson JE, Ridker PM, Spelsberg A, Ajani U, Lotufo PA, Hennekens CH . Vasectomy and subsequent cardiovascular disease in US physicians. Contraception 1999; 59(3):181-6.
28. Lesko SM, Louik C, Vezina R, Rosenberg L, Shapiro S . Vasectomy and prostate cancer. J Urol 1999; 161(6): 1848-52; discussion 1852-3.
29. Dennis LK, Dawson DV, Resnick MI . Vasectomy and the risk of prostate cancer: a meta-analysis examining vasectomy status, age at vasectomy, and time since vasectomy. Prostate Cancer Prostatic Dis 2002; 5(3): 193-203.
30. Møller H, Knudsen LB, Lynge E . Risk of testicular cancer after vasectomy: cohort study of over 73,000 men. BMJ 1994; 309(6950): 295-9.
31. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Strom BL, Harlap S et al. The relation of vasectomy to the risk of cancer. Am J Epidemiol 1994; 140(5): 431-8.
32. Buchholz NP, Weuste R, Mattarelli G, Woessmer B, Langewitz W . Post-vasectomy erectile dysfunction. J Psychosom Res 1994; 38(7): 759-62.
33. Rhoden EL, Telöken C, Sogari PR, Vargas Souto CA .The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int J Impot Res 2002; 14(4): 245-50.